Analgesic effects and arthritic changes following tramadol administration in a rat hip osteoarthritis model
- 15 November 2021
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 40 (8) , 1770-1777
Abstract
We investigated the analgesic effects of tramadol and the arthritic changes following tramadol administration in the rat hip osteoarthritis (OA) model using mono‐iodoacetate (MIA). The right hip joints of male Sprague–Dawley rats (n = 5 rats/group) in the Sham group were injected with 25 μl of sterile saline and 1% of fluorogold (FG) retrograde neurotracer. In the MIA + Vehicle and MIA + Tramadol groups, FG and 25 μl of sterile saline with 0.5 mg of MIA were injected into the right hip joint. The MIA + Vehicle and MIA + Tramadol groups were administered daily for 4 weeks, either sterile saline (10 mg/kg, intraperitoneal [i.p.]) or tramadol (10 mg/kg, i.p.). We assessed hyperalgesia every week after MIA administration. Histopathological changes and immunoreactive neurons for calcitonin gene‐related peptide (CGRP) in dorsal root ganglia (DRG) were evaluated after 4 weeks of treatment. MIA injection into the hip joint led to mechanical hyperalgesia (p < 0.01), which was significantly reduced by tramadol administration (p < 0.01). Furthermore, daily i.p injection of tramadol significantly suppressed CGRP expression in DRG (p < 0.0001). MIA + Vehicle and MIA + Tramadol groups showed significant cartilage reduction and degeneration compared to the Sham group (p < 0.0001). Interestingly, OA changes significantly progressed in the MIA + Tramadol group compared to the MIA + Vehicle group (p < 0.0001).Keywords
This publication has 45 references indexed in Scilit:
- Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the KneeClinical Drug Investigation, 2010
- Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind studyCurrent Medical Research and Opinion, 2009
- d-Cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry ☆Pain, 2007
- Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer painExperimental Neurology, 2005
- Calcitonin Gene-Related Peptide Receptor Activation Produces PKA- and PKC-Dependent Mechanical Hyperalgesia and Central SensitizationJournal of Neurophysiology, 2004
- Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the kneeJournal of Pain and Symptom Management, 2004
- Expression of functional μ-opioid receptors in human osteoarthritic cartilage and chondrocytesBiochemical and Biophysical Research Communications, 2003
- Mono-Iodoacetate-Induced Histologic Changes in Subchondral Bone and Articular Cartilage of Rat Femorotibial Joints: An Animal Model of OsteoarthritisToxicologic Pathology, 2003
- TramadolDrugs, 2000
- Activating Transcription Factor 3 (ATF3) Induction by Axotomy in Sensory and Motoneurons: A Novel Neuronal Marker of Nerve InjuryMolecular and Cellular Neuroscience, 2000